140 related articles for article (PubMed ID: 32199326)
1. In vitro investigations on dopamine loaded Solid Lipid Nanoparticles.
Cometa S; Bonifacio MA; Trapani G; Di Gioia S; Dazzi L; De Giglio E; Trapani A
J Pharm Biomed Anal; 2020 Jun; 185():113257. PubMed ID: 32199326
[TBL] [Abstract][Full Text] [Related]
2. Intranasal delivery of dopamine to the striatum using glycol chitosan/sulfobutylether-β-cyclodextrin based nanoparticles.
Di Gioia S; Trapani A; Mandracchia D; De Giglio E; Cometa S; Mangini V; Arnesano F; Belgiovine G; Castellani S; Pace L; Lavecchia MA; Trapani G; Conese M; Puglisi G; Cassano T
Eur J Pharm Biopharm; 2015 Aug; 94():180-93. PubMed ID: 26032293
[TBL] [Abstract][Full Text] [Related]
3. Dopamine-loaded lipid based nanocarriers for intranasal administration of the neurotransmitter: A comparative study.
Trapani A; De Giglio E; Cometa S; Bonifacio MA; Dazzi L; Di Gioia S; Hossain MN; Pellitteri R; Antimisiaris SG; Conese M
Eur J Pharm Biopharm; 2021 Oct; 167():189-200. PubMed ID: 34333085
[TBL] [Abstract][Full Text] [Related]
4. Design, characterization, and evaluation of intranasal delivery of ropinirole-loaded mucoadhesive nanoparticles for brain targeting.
Jafarieh O; Md S; Ali M; Baboota S; Sahni JK; Kumari B; Bhatnagar A; Ali J
Drug Dev Ind Pharm; 2015; 41(10):1674-81. PubMed ID: 25496439
[TBL] [Abstract][Full Text] [Related]
5. Design, biometric simulation and optimization of a nano-enabled scaffold device for enhanced delivery of dopamine to the brain.
Pillay S; Pillay V; Choonara YE; Naidoo D; Khan RA; du Toit LC; Ndesendo VM; Modi G; Danckwerts MP; Iyuke SE
Int J Pharm; 2009 Dec; 382(1-2):277-90. PubMed ID: 19703530
[TBL] [Abstract][Full Text] [Related]
6. Biopharmaceutical Potential of Selegiline Loaded Chitosan Nanoparticles in the Management of Parkinson's Disease.
Rukmangathen R; Yallamalli IM; Yalavarthi PR
Curr Drug Discov Technol; 2019; 16(4):417-425. PubMed ID: 29669501
[TBL] [Abstract][Full Text] [Related]
7. Pramipexole dihydrochloride loaded chitosan nanoparticles for nose to brain delivery: Development, characterization and in vivo anti-Parkinson activity.
Raj R; Wairkar S; Sridhar V; Gaud R
Int J Biol Macromol; 2018 Apr; 109():27-35. PubMed ID: 29247729
[TBL] [Abstract][Full Text] [Related]
8. Self-reporter shikonin-Act-loaded solid lipid nanoparticle: formulation, physicochemical characterization and geno/cytotoxicity evaluation.
Eskandani M; Nazemiyeh H
Eur J Pharm Sci; 2014 Aug; 59():49-57. PubMed ID: 24768857
[TBL] [Abstract][Full Text] [Related]
9. Sumatriptan succinate loaded chitosan solid lipid nanoparticles for enhanced anti-migraine potential.
Hansraj GP; Singh SK; Kumar P
Int J Biol Macromol; 2015 Nov; 81():467-76. PubMed ID: 26299709
[TBL] [Abstract][Full Text] [Related]
10. Improved oral delivery of resveratrol from N-trimethyl chitosan-g-palmitic acid surface-modified solid lipid nanoparticles.
Ramalingam P; Ko YT
Colloids Surf B Biointerfaces; 2016 Mar; 139():52-61. PubMed ID: 26700233
[TBL] [Abstract][Full Text] [Related]
11. Solid lipid nanoparticles for oral drug delivery: chitosan coating improves stability, controlled delivery, mucoadhesion and cellular uptake.
Luo Y; Teng Z; Li Y; Wang Q
Carbohydr Polym; 2015 May; 122():221-9. PubMed ID: 25817662
[TBL] [Abstract][Full Text] [Related]
12. Dopamine-loaded chitosan nanoparticles: formulation and analytical characterization.
De Giglio E; Trapani A; Cafagna D; Sabbatini L; Cometa S
Anal Bioanal Chem; 2011 Jun; 400(7):1997-2002. PubMed ID: 21523332
[TBL] [Abstract][Full Text] [Related]
13. Brain-targeted intranasal delivery of dopamine with borneol and lactoferrin co-modified nanoparticles for treating Parkinson's disease.
Tang S; Wang A; Yan X; Chu L; Yang X; Song Y; Sun K; Yu X; Liu R; Wu Z; Xue P
Drug Deliv; 2019 Dec; 26(1):700-707. PubMed ID: 31290705
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics of intranasally administered selegiline nanoparticles with improved brain delivery in Parkinson's disease.
Sridhar V; Gaud R; Bajaj A; Wairkar S
Nanomedicine; 2018 Nov; 14(8):2609-2618. PubMed ID: 30171904
[TBL] [Abstract][Full Text] [Related]
15. Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model.
Md S; Khan RA; Mustafa G; Chuttani K; Baboota S; Sahni JK; Ali J
Eur J Pharm Sci; 2013 Feb; 48(3):393-405. PubMed ID: 23266466
[TBL] [Abstract][Full Text] [Related]
16. Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery.
Trapani A; De Giglio E; Cafagna D; Denora N; Agrimi G; Cassano T; Gaetani S; Cuomo V; Trapani G
Int J Pharm; 2011 Oct; 419(1-2):296-307. PubMed ID: 21821107
[TBL] [Abstract][Full Text] [Related]
17. New synthetic adriamycin-incorporated chitosan nanoparticles with enhanced antioxidant, antitumor activities and pH-sensitive drug release.
Mi Y; Chen Y; Gu G; Miao Q; Tan W; Li Q; Guo Z
Carbohydr Polym; 2021 Dec; 273():118623. PubMed ID: 34561017
[TBL] [Abstract][Full Text] [Related]
18. Trans-blood brain barrier delivery of dopamine-loaded nanoparticles reverses functional deficits in parkinsonian rats.
Pahuja R; Seth K; Shukla A; Shukla RK; Bhatnagar P; Chauhan LK; Saxena PN; Arun J; Chaudhari BP; Patel DK; Singh SP; Shukla R; Khanna VK; Kumar P; Chaturvedi RK; Gupta KC
ACS Nano; 2015 May; 9(5):4850-71. PubMed ID: 25825926
[TBL] [Abstract][Full Text] [Related]
19. Cyto/Biocompatibility of Dopamine Combined with the Antioxidant Grape Seed-Derived Polyphenol Compounds in Solid Lipid Nanoparticles.
Trapani A; Guerra L; Corbo F; Castellani S; Sanna E; Capobianco L; Monteduro AG; Manno DE; Mandracchia D; Di Gioia S; Conese M
Molecules; 2021 Feb; 26(4):. PubMed ID: 33572331
[No Abstract] [Full Text] [Related]
20. Fabrication of letrozole formulation using chitosan nanoparticles through ionic gelation method.
Gomathi T; Sudha PN; Florence JAK; Venkatesan J; Anil S
Int J Biol Macromol; 2017 Nov; 104(Pt B):1820-1832. PubMed ID: 28185930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
